Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine
Alan Chen-Yu HsuPhilip M Hansbro

Abstract

Chronic obstructive pulmonary disease (COPD) and influenza virus infections are major global health issues. Patients with COPD are more susceptible to infection, which exacerbates their condition and increases morbidity and mortality. The mechanisms of increased susceptibility remain poorly understood, and current preventions and treatments have substantial limitations. To characterize the mechanisms of increased susceptibility to influenza virus infection in COPD and the potential for therapeutic targeting. We used a combination of primary bronchial epithelial cells (pBECs) from COPD and healthy control subjects, a mouse model of cigarette smoke-induced experimental COPD, and influenza infection. The role of the phosphoinositide-3-kinase (PI3K) pathway was characterized using molecular methods, and its potential for targeting assessed using inhibitors. COPD pBECs were susceptible to increased viral entry and replication. Infected mice with experimental COPD also had more severe infection (increased viral titer and pulmonary inflammation, and compromised lung function). These processes were associated with impaired antiviral immunity, reduced retinoic acid-inducible gene-I, and IFN/cytokine and chemokine responses. Increased PI...Continue Reading

References

Mar 1, 1980·The Journal of Infectious Diseases·C B SmithA D Renzetti
Jan 1, 1980·Journal of Virological Methods·J Huprikar, S Rabinowitz
Sep 8, 1998·Clinical and Diagnostic Laboratory Immunology·D GentileD Skoner
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·T SeemungalJ A Wedzicha
Feb 15, 2002·Current Opinion in Pulmonary Medicine·Federico P Gómez, Roberto Rodriguez-Roisin
Mar 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jennifer H DufourAndrew D Luster
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·John C Williamson, P Samuel Pegram
Sep 1, 2004·The Journal of Experimental Medicine·Borja G CosioPeter J Barnes
May 13, 2005·The New England Journal of Medicine·Kazuhiro ItoPeter J Barnes
Sep 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Benjamin G HaleRichard E Randall
Apr 24, 2009·Annual Review of Microbiology·Terrence M Tumpey, Jessica A Belser
Sep 11, 2009·Journal of Virology·Ewan F DunnJohn H Connor
Sep 25, 2009·The New England Journal of Medicine·Arnold S MontoJohn C Victor
Nov 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michelle D TatePatrick C Reading
Jan 1, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masafumi SekiTheodore J Standiford
Mar 13, 2010·American Journal of Respiratory and Critical Care Medicine·Yasuo ToPeter J Barnes
Mar 17, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jay C HorvatPhilip M Hansbro
Apr 20, 2010·Critical Care Medicine·Kevin LoweTroy Stevens
Apr 24, 2010·Journal of Experimental & Clinical Cancer Research : CR·Hanguo JiangHuihua Deng
May 28, 2010·Respiratory Research·Modestos A ModestouDwight C Look
Aug 14, 2010·American Journal of Respiratory Cell and Molecular Biology·Alan Chen-Yu HsuPeter A Wark
Oct 5, 2010·American Journal of Respiratory and Critical Care Medicine·Patrick MalliaSebastian L Johnston
Feb 22, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Wenxin WuJordan P Metcalf
Oct 28, 2011·The New England Journal of Medicine·John E McDonoughJames C Hogg
Nov 18, 2011·Mucosal Immunology·S KeelyP M Hansbro
Dec 30, 2011·The New England Journal of Medicine·Aeron C HurtAnne Kelso
Mar 9, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Jamie L GarfieldGerard J Criner
Mar 31, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alison N ThorburnPhilip M Hansbro
May 24, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Alan C-Y HsuPeter A B Wark
Feb 6, 2013·The Journal of Allergy and Clinical Immunology·Emma L BeckettPhilip M Hansbro
Apr 24, 2014·Expert Opinion on Drug Discovery·Michael FrickerPhilip M Hansbro
Jun 24, 2014·Nature Immunology·Bernardo S FranklinEicke Latz

❮ Previous
Next ❯

Citations

Feb 3, 2016·Trends in Pharmacological Sciences·Chantal DonovanRoss Vlahos
Jan 26, 2016·Pulmonary Pharmacology & Therapeutics·Zhilong Jiang, Lei Zhu
Sep 18, 2015·American Journal of Respiratory Cell and Molecular Biology·Malcolm R StarkeyPhilip M Hansbro
May 14, 2016·Seminars in Immunopathology·Jahar Bhattacharya, Kristin Westphalen
May 14, 2016·American Journal of Respiratory and Critical Care Medicine·Nathaniel Marchetti, Gerard J Criner
May 13, 2017·The International Journal of Biochemistry & Cell Biology·Md Khadem AliJay C Horvat
Mar 28, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Janice M LeungSanjay H Chotirmall
Jan 20, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Sanjay H ChotirmallPhilip M Hansbro
Jun 29, 2017·Immunological Reviews·Philip M HansbroJay C Horvat
Mar 11, 2018·Biochemical Society Transactions·Clare A Stokes, Alison M Condliffe
Oct 13, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Bernadette JonesPhilip M Hansbro
Sep 28, 2018·Journal of Leukocyte Biology·Chantal DonovanPhilip M Hansbro
Nov 20, 2018·Laboratory Investigation; a Journal of Technical Methods and Pathology·Mathew Suji EapenSukhwinder Singh Sohal
Jan 22, 2019·Mucosal Immunology·Malcolm R StarkeyPhilip M Hansbro
May 26, 2017·The European Respiratory Journal·Philip M HansbroKensuke Miyake
Nov 2, 2017·Mucosal Immunology·M J HongF Kheradmand
Feb 26, 2019·The Journal of Pharmacology and Experimental Therapeutics·Robbie L McLeodSanjiv Shah
Jul 25, 2019·Immunology and Cell Biology·Thomas J HaymanSandra E Nicholson
Oct 31, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Shakti D ShuklaPhilip M Hansbro
Mar 7, 2020·Expert Review of Respiratory Medicine·Federica Lo BelloGaetano Caramori
Mar 19, 2020·The European Respiratory Journal·Md Khadem AliJay C Horvat
Dec 8, 2017·BMC Infectious Diseases·Naoko KatsuradaUNKNOWN Adult Pneumonia Study Group-Japan
Aug 2, 2020·The Journal of Pathology·Bernadette Jones-Freeman, Malcolm R Starkey
Jan 20, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jodie L SimpsonPhilip M Hansbro
Mar 21, 2018·Frontiers in Immunology·Alison M Condliffe, Anita Chandra
May 14, 2019·Expert Opinion on Therapeutic Targets·Gaetano CaramoriIan M Adcock
Aug 3, 2020·Archives of Virology·Javier BlancoIsabel Muñoz-Barroso

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.